How much did DocCheck achieve in EBIT for the current year?
In the current year, DocCheck has achieved an EBIT of 3.76 M EUR.
DocCheck EBIT 2024
DocCheck EBIT
3.76 M EUR
Ticker
AJ91.DE
ISIN
DE000A1A6WE6
WKN
A1A6WE
In 2024, DocCheck's EBIT was 3.76 M EUR, a -64.48% increase from the 10.6 M EUR EBIT recorded in the previous year.
The DocCheck EBIT history
| YEAR | EBIT (undefined EUR) |
|---|---|
| 2023 | 3.76 |
| 2022 | 10.6 |
| 2021 | 16.87 |
| 2020 | 14.13 |
| 2019 | 4.71 |
| 2018 | 3.9 |
| 2017 | 3.74 |
| 2016 | 4.19 |
| 2015 | 4.01 |
| 2014 | 2.53 |
| 2013 | 1.41 |
| 2012 | 1.55 |
| 2011 | 1.83 |
| 2010 | 1.21 |
| 2009 | 1.04 |
| 2008 | 0.62 |
| 2007 | 0.33 |
| 2006 | 1.1 |
| 2005 | 0.48 |
| 2004 | 0.43 |
DocCheck Revenue, EBIT, Net Income DE000A1A6WE6 · A1A6WE
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into DocCheck, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DocCheck from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DocCheck’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of DocCheck. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into DocCheck’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing DocCheck’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DocCheck’s growth potential.
DocCheck Revenue, EBIT and net profit per share
| Date | DocCheck Revenue | DocCheck EBIT | DocCheck Net Income |
|---|---|---|---|
| 2023 | 53.41 M EUR | 3.76 M EUR | 2.27 M EUR |
| 2022 | 60.9 M EUR | 10.6 M EUR | 6.29 M EUR |
| 2021 | 85.92 M EUR | 16.87 M EUR | 11.4 M EUR |
| 2020 | 63.1 M EUR | 14.13 M EUR | 9.2 M EUR |
| 2019 | 32.38 M EUR | 4.71 M EUR | 3.14 M EUR |
| 2018 | 28.33 M EUR | 3.9 M EUR | 2.27 M EUR |
| 2017 | 28.07 M EUR | 3.74 M EUR | 2.41 M EUR |
| 2016 | 25.92 M EUR | 4.19 M EUR | 2.66 M EUR |
| 2015 | 26.8 M EUR | 4.01 M EUR | 2.88 M EUR |
| 2014 | 19.89 M EUR | 2.53 M EUR | 1.69 M EUR |
| 2013 | 17.78 M EUR | 1.41 M EUR | 1.09 M EUR |
| 2012 | 18.29 M EUR | 1.55 M EUR | 1.11 M EUR |
| 2011 | 18.03 M EUR | 1.83 M EUR | 1.39 M EUR |
| 2010 | 15.62 M EUR | 1.21 M EUR | 760,000 EUR |
| 2009 | 16.46 M EUR | 1.04 M EUR | 610,000 EUR |
| 2008 | 15.7 M EUR | 620,000 EUR | 600,000 EUR |
| 2007 | 14.91 M EUR | 330,000 EUR | 660,000 EUR |
| 2006 | 13.78 M EUR | 1.1 M EUR | 910,000 EUR |
| 2005 | 11.34 M EUR | 480,000 EUR | 640,000 EUR |
| 2004 | 10.75 M EUR | 430,000 EUR | 650,000 EUR |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 10.75 M EUR | 430,000 EUR | 650,000 EUR |
| 2005 | 11.34 M EUR | 480,000 EUR | 640,000 EUR |
| 2006 | 13.78 M EUR | 1.1 M EUR | 910,000 EUR |
| 2007 | 14.91 M EUR | 330,000 EUR | 660,000 EUR |
| 2008 | 15.7 M EUR | 620,000 EUR | 600,000 EUR |
| 2009 | 16.46 M EUR | 1.04 M EUR | 610,000 EUR |
| 2010 | 15.62 M EUR | 1.21 M EUR | 760,000 EUR |
| 2011 | 18.03 M EUR | 1.83 M EUR | 1.39 M EUR |
| 2012 | 18.29 M EUR | 1.55 M EUR | 1.11 M EUR |
| 2013 | 17.78 M EUR | 1.41 M EUR | 1.09 M EUR |
| 2014 | 19.89 M EUR | 2.53 M EUR | 1.69 M EUR |
| 2015 | 26.8 M EUR | 4.01 M EUR | 2.88 M EUR |
| 2016 | 25.92 M EUR | 4.19 M EUR | 2.66 M EUR |
| 2017 | 28.07 M EUR | 3.74 M EUR | 2.41 M EUR |
| 2018 | 28.33 M EUR | 3.9 M EUR | 2.27 M EUR |
| 2019 | 32.38 M EUR | 4.71 M EUR | 3.14 M EUR |
| 2020 | 63.1 M EUR | 14.13 M EUR | 9.2 M EUR |
| 2021 | 85.92 M EUR | 16.87 M EUR | 11.4 M EUR |
| 2022 | 60.9 M EUR | 10.6 M EUR | 6.29 M EUR |
| 2023 | 53.41 M EUR | 3.76 M EUR | 2.27 M EUR |
DocCheck stock margins DE000A1A6WE6 · A1A6WE
The DocCheck margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocCheck. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocCheck.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the DocCheck's sales revenue. A higher gross margin percentage indicates that the DocCheck retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the DocCheck's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the DocCheck's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DocCheck's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DocCheck. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DocCheck's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
DocCheck Margin History
| DocCheck Gross margin | DocCheck Profit margin | DocCheck EBIT margin | DocCheck Profit margin |
|---|---|---|---|
| 2023 | 80.89 % | 7.05 % | 4.25 % |
| 2022 | 75.17 % | 17.41 % | 10.33 % |
| 2021 | 57.86 % | 19.63 % | 13.27 % |
| 2020 | 63.9 % | 22.39 % | 14.58 % |
| 2019 | 80.23 % | 14.55 % | 9.7 % |
| 2018 | 79.63 % | 13.77 % | 8.01 % |
| 2017 | 77.38 % | 13.32 % | 8.59 % |
| 2016 | 76.27 % | 16.17 % | 10.26 % |
| 2015 | 72.87 % | 14.96 % | 10.75 % |
| 2014 | 76.87 % | 12.72 % | 8.5 % |
| 2013 | 73.79 % | 7.93 % | 6.13 % |
| 2012 | 72.33 % | 8.47 % | 6.07 % |
| 2011 | 71.16 % | 10.15 % | 7.71 % |
| 2010 | 73.82 % | 7.75 % | 4.87 % |
| 2009 | 74.36 % | 6.32 % | 3.71 % |
| 2008 | 72.68 % | 3.95 % | 3.82 % |
| 2007 | 74.78 % | 2.21 % | 4.43 % |
| 2006 | 75.54 % | 7.98 % | 6.6 % |
| 2005 | 72.84 % | 4.23 % | 5.64 % |
| 2004 | 74.6 % | 4 % | 6.05 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 74.6 % | 4 % | 6.05 % |
| 2005 | 72.84 % | 4.23 % | 5.64 % |
| 2006 | 75.54 % | 7.98 % | 6.6 % |
| 2007 | 74.78 % | 2.21 % | 4.43 % |
| 2008 | 72.68 % | 3.95 % | 3.82 % |
| 2009 | 74.36 % | 6.32 % | 3.71 % |
| 2010 | 73.82 % | 7.75 % | 4.87 % |
| 2011 | 71.16 % | 10.15 % | 7.71 % |
| 2012 | 72.33 % | 8.47 % | 6.07 % |
| 2013 | 73.79 % | 7.93 % | 6.13 % |
| 2014 | 76.87 % | 12.72 % | 8.5 % |
| 2015 | 72.87 % | 14.96 % | 10.75 % |
| 2016 | 76.27 % | 16.17 % | 10.26 % |
| 2017 | 77.38 % | 13.32 % | 8.59 % |
| 2018 | 79.63 % | 13.77 % | 8.01 % |
| 2019 | 80.23 % | 14.55 % | 9.7 % |
| 2020 | 63.9 % | 22.39 % | 14.58 % |
| 2021 | 57.86 % | 19.63 % | 13.27 % |
| 2022 | 75.17 % | 17.41 % | 10.33 % |
| 2023 | 80.89 % | 7.05 % | 4.25 % |
DocCheck Aktienanalyse
What does DocCheck do?
DocCheck AG is a German company that was established in Cologne in 1996. It is the largest European specialist portal for medical professionals and provides various products and services for doctors, pharmacists, and pharmaceutical professionals. Initially, the company focused primarily on offering continuing education for doctors and job placement in the medical field. However, soon the business model expanded and additional sectors were added. An important pillar of the company is the online portal DocCheck.com. Here, medical professionals can register and gain access to exclusive content including specialized articles, studies, and videos, as well as receive updates and news from the medical field. Additionally, the company offers a wide range of medical workwear and accessories. The products range from disposable gloves to stethoscopes and medical torches. The assortment is regularly updated and expanded. Another important area of focus is job placement in the medical sector. DocCheck is one of the largest providers on the German market for medical job advertisements. Employers can place ads for a fee, and job seekers can find suitable job offers. A special highlight for customers is the so-called DocCheck Flexikon. It is an online lexicon for medical terms, continuously revised and updated by specialists. The Flexikon is also available as a smartphone and tablet app. Overall, DocCheck is a company with a wide range of products and services tailored to the needs of medical professionals. In recent years, the company has become an important partner in the healthcare sector in Germany and Europe, and it has become an essential player in the industry. DocCheck ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing DocCheck's EBIT
DocCheck's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of DocCheck's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
DocCheck's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in DocCheck’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about DocCheck stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company DocCheck.
How has the EBIT of DocCheck developed in recent years?
The EBIT of DocCheck has increased by -64.483% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company DocCheck?
The EBIT of DocCheck is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does DocCheck pay?
Over the past 12 months, DocCheck paid a dividend of 0.75 EUR . This corresponds to a dividend yield of about 7.98 %. For the coming 12 months, DocCheck is expected to pay a dividend of 0.75 EUR.
What is the dividend yield of DocCheck?
The current dividend yield of DocCheck is 7.98 %.
When does DocCheck pay dividends?
DocCheck pays a quarterly dividend. This is distributed in the months of June, July, July, June.
How secure is the dividend of DocCheck?
DocCheck paid dividends every year for the past 12 years.
What is the dividend of DocCheck?
For the upcoming 12 months, dividends amounting to 0.75 EUR are expected. This corresponds to a dividend yield of 7.98 %.
In which sector is DocCheck located?
DocCheck is assigned to the 'Health' sector.
Wann musste ich die Aktien von DocCheck kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DocCheck from 6/3/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
When did DocCheck pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of DocCheck in the year 2023?
In the year 2023, DocCheck distributed 1 EUR as dividends.
In which currency does DocCheck pay out the dividend?
The dividends of DocCheck are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DocCheck
Our stock analysis for DocCheck Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocCheck Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
